Krka, d. d. (LJSE:KRKG)

Market Cap	5.42B
Revenue (ttm)	1.91B
Net Income (ttm)	356.99M
Shares Out	30.60M
EPS (ttm)	11.60
PE Ratio	15.26
Forward PE	14.88
Dividend	7.50 (4.24%)
Ex-Dividend Date	Jul 23, 2024

Volume	5,142
Average Volume	6,186
Open	177.50
Previous Close	177.00
Day's Range	177.00 - 179.50
52-Week Range	124.50 - 179.50
Beta	0.44
RSI	64.69
Earnings Date	May 15, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.